Providing a scientific forum for practical applications and theoretical advances of Artificial Intelligence (AI) in the life sciences and related disciplines including (but not restricted to):New AI methods for life science researchAdaptation of existing AI concepts for life science applicationsApplication of AI approaches in: Molecular and systems biologyPopulation and disease geneticsBio- and cheminformaticsMedicinal chemistry, chemical biology, and drug discoveryMedical researchPublications are required to contain substantial AI and life science components. Clinical studies reporting routine diagnostic efforts hall outside the scope of AILSCI.Background: Artificial Intelligence originates from computer science and covers a wide range of approaches intended to enhance the ability of machines to make data-driven decisions and accurate predictions of events. In many scientific fields, AI is being increasingly considered and integrated, especially in the context of Big Data. Given their complexity and highly interdisciplinary nature, the life sciences provide ample opportunities for AI to impact R&D efforts in a variety of ways.Key words: Artificial Intelligence; Life Sciences; Drug Discovery; Bio- and Cheminformatics, Machine Learning; Machine Intelligence; Deep Learning; Data Mining; Big Data.
Frontiers in Laboratory Medicine publishes rigorously peer-reviewed, high-quality original articles and authoritative reviews that focus on developments and advances in laboratory medicine. An emphasis is placed on diagnostic technology, investigations relevant to clinical laboratories, and experimental studies of diseases. This journal has a worldwide authorship and is required reading for professionals working in the following areas:Molecular Diagnostics and GeneticsGeneral Clinical ChemistryClinical ImmunologyProteomics and BiomarkersMicroarray Technology and SequencingMass SpectrometryNanotechnology and Biological materialElectrochemistry and BiosensorsRapid / Cost-effective Laboratory MethodsAutomation and Analytical TechniquesBio-informatics and StatisticsAnimal Laboratory MedicineCancer DiagnosticsDiagnostic Microbiology and Infectious DiseaseLipoproteins and Cardiovascular Risk FactorsHemostasis and ThrombosisDrug Monitoring and ToxicologyHematologyEndocrinology and MetabolismLaboratory ManagementOther Areas of Laboratory Medicine
Future Healthcare Journal (FHJ) is a peer-reviewed academic journal with a multidisciplinary editorial board stimulating debate about all aspects of future healthcare. Each issue has a theme featuring commissioned articles from national and international experts providing authoritative overviews as well as submitted papers. Themed issues are published online when collated but all accepted articles are available immediately for rapidity of referencing and citation. Articles feature digital health and artificial intelligence, illness prevention, multidisciplinary workforce planning, system re-engineering, population health, lifestyle medicine and therapeutic advances. The emphasis is on providing practical solutions to current healthcare challenges. It has strong involvement of trainees and encourages submissions on QI and audit rarely found in other journals. FHJ tackles contentious issues and aims to provide readers with the tools to facilitate transformational change at an individual and organisational level. Articles should be of interest and understandable to a broad audience of healthcare professionals and leaders who may be involved in making system changes in their own organisation.  While the journal is affiliated with the Royal College of Physicians (RCP), it has full editorial independence.From January 1, 2024, Future Healthcare Journal becomes a full gold open access journal freely available for everyone to access and read. All articles submitted after January 1, 2024, are subject to an article publishing charge (APC) after peer review and acceptance. We are pleased to inform you that Future Healthcare Journal waives the APC (Article Publishing Charge) for all submissions received before 31 December 2025, which are accepted for publication after peer review. Learn more about hybrid journals moving to open access.
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.
Peer Review under the responsibility of the Indian Heart Rhythm Society.Indian Pacing and Electrophysiology Journal (IPEJ) is the official journal of the Indian Heart Rhythm Society with a world-wide readership and accepts manuscripts for publication from across the globe. IPEJ aims to publish high quality articles on all aspects of cardiac pacing and electrophysiology including basic research. The journal follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org). It follows the policy of open-access and is published bi-monthly. All the manuscripts are peer-reviewed except the editorials that are usually on invitation only. All opinions and conclusions stated in the articles are exclusively that of the author(s) and need not represent the views of the editors or publishers.
NeuroMarkers is an international, peer-reviewed, open access journal that aims to publish the high-quality, innovative research that addresses biomarker investigation from all Nervous System Diseases. The journal studies the identification and validation of biomarkers in neurological diseases to aid diagnosis, prognosis, response to therapy, and elucidating mechanisms. Also aims to reduce the incidence of misdiagnoses and inappropriate treatment.The scope of the journal includes, but is not limited to: Cellular & Molecular Biomarkers Neuroimaging Biomarkers Developmental Biomarkers Cognitive Biomarkers Behavioural Biomarkers Ageing Biomarkers AI-Generated MarkersEditorial Board
URINE promotes basic research, translation and clinical applications in the area of urine, with the aim of improving understanding, screening, diagnosis, treatment monitoring and disease management. The journal not only accelerates the development of research in this field but helps to build connections between the diverse communities involved in urine research.The next generation of biomarker is projected to rely heavily upon urinary biomarkers to stratify risk, diagnose disease, determine optimal treatment strategies, evaluate drug response and monitor disease progression.These objectives are achieved by providing a fast, author-focused publication process. All types of papers are welcome, and each submission benefits from expert peer-review. To protect the novelty of authors, URINE encourages and welcomes the submission of manuscripts that have already been posted on a preprint archive.Submissions on a variety of urine-related topics will be considered. These include, but are not limited to, papers addressing:Urinary biomarker discovery and validation and the development of various systematic diseases.Disease development observations from changes in urine.Screening for early signs of pathophysiological processes in the body.Disease management and treatment based on early diagnosis of the diseases in urine.Technological developments that can potentially be applied to the field of urine, either in basic research or clinical applications, for example, biobanking methods of various urine components.Bioinformatics related to urinary biomarker studies.Urinary extracellular vesiclesUrinary-based liquid biopsiesIn recognition of the breadth of the research communities active in biomarker studies, the URINE Executive Editorial board will consist of four types of researchers at all times:Clinical domain expertsExperts in physiology, biology, biochemistry and related disciplinesStatistical and experimental design expertsEngineering expertsThis will help to ensure that the journal can reliably evaluate a range of studies and maintain a diverse collection of articles.